Skip to main content
SpringerLink
Log in

Thiobarbiturate and fructosamine assays: significance and interest of the borohydride blank

  • Originals
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

The acute-phase reaction (APR) induces the production by the liver of short-lived glycoproteins. The carbohydrate moiety of these proteins is thought to interfere with the thiobarbiturate (TBA) and nitroblue tetrazolium colorimetric tests which are used for assaying non-enzymatic glycosylation (NEG) of serum proteins. The aim of the present study was to assess the effect of the APR on the specificity of the colorimetric tests in non-diabetic and diabetic subjects. A positive correlation was found between C-reactive protein (CRP), an APR glycoprotein, and non-specific TBA reactivity as determined after borohydride reduction (BH4-resistant TBA, BR-TBA), both in non-diabetics (r=0.61;P<0.01) and diabetics (r=0.68;P<0.01). The BH4-sensitive specific TBA (SP-TBA) was not influenced by glycoproteins, and its increase in diabetics was correlated with the nitroblue tetrazolium assay (r=0.89;P<0.01). An independant effect of diabetes and APR on non-specific TBA was also demonstrated, suggesting an effect of hyperglycaemia on both protein glycation and glycosylation. TBA with borohydride reduction is an attractive tool for the study of complex glycoproteins in diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Steffes MW, Mauer SM, Toward a basic understanding of diabetes complications. N Engl J Med 325:883–884, 1991

    Google Scholar 

  2. Larsen ML, Horder M, Mogensen EF, Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 323:1021–1025, 1990

    Google Scholar 

  3. Kennedy L, Mehl TD, Riley WJ, Merimee TJ, Non-enzymatically glycosylated serum protein in diabetes mellitus: an index of short-term glycemia. Diabetologia 21:94–98, 1981

    Google Scholar 

  4. Elder E, Kennedy L, Rapid, accurate colorimetric assay of non-enzymatically glycosylated serum proteins. Diabetologia 24:70–71, 1983

    Google Scholar 

  5. Cefalu WT, Bell-Farrow AD, Petty M, Izlar C, Smith JA, Clinical validation of a second-generation fructosamine assay. Clin Chem 37:1252–1256, 1991

    Google Scholar 

  6. Armbuster A, Fructosamine: structure, analysis and clinical usefulness. Clin Chem 33:2153–2163, 1987

    Google Scholar 

  7. Schleicher ED, Mayer R, Wagner EM, Gerbitz KD, Is serum fructosamine assay specific for determination of glycated serum protein?. Clin Chem 34:320–323, 1988

    Google Scholar 

  8. Montreuil J, Bouquelet S, Debray H, Fouret B, Spik G, Stecker G. Glycoproteins. In: Chaplin MF, Kennedy JF (eds) Carbohydrate analysis: a practical approach. IRL, Oxford, pp 143–204, 1986

    Google Scholar 

  9. Keeney M, Bassette R, Detection of intermediate compounds in the early stages of browning reaction in milk products. Clin Chim Acta, 22:296–298, 1968

    Google Scholar 

  10. Knight J, Pieper R, McLellan L, Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem 34:2433–2438, 1988

    Google Scholar 

  11. Pepys MB, Baltz ML, Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid a protein. Adv Immunol 34:142–212, 1983

    Google Scholar 

  12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254, 1976

    Google Scholar 

  13. Dolhofer R, Wieland OH, Improvement of the thiobarbituric acid assay for serum glycosylprotein determination. Clin Chim Acta 112:197–204, 1981

    Google Scholar 

  14. Kennedy AL, Merimee TJ, Glycosylated serum protein and hemoglobin A1 levels to measure control of glycemia. Ann Intern Med 95:56–58, 1981

    Google Scholar 

  15. Parker KM, England JD, Dacosta J, Hess RL, Goldstein D, Improved colorimetric assay for glycosylated hemoglobin. Clin Chem 27:669–672, 1981

    Google Scholar 

  16. Johnson RN, Metcalf PA, Baker JR, Fructosamine: A new approach to the estimaton of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127:87–95, 1982

    Google Scholar 

  17. Gewurz H, Mold C, Siegel J, Fiedel B, C-reactive protein and the acute phase response. Adv Intern Med 27:345–372, 1982

    Google Scholar 

  18. Rosner B, Fundamentals of biostatistics. Duxbury, Boston, pp 439–447, 1982

    Google Scholar 

  19. Bookchin RM, Gallop PM, Structure of hemoglobin A1C: Nature of the N-terminal B chain blocking group. Biochem Biophys Res Commun 1:86–93, 1968

    Google Scholar 

  20. Rahbar S, An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta 22:296–298, 1968

    Google Scholar 

  21. Maillard LC, Action des acides amines sur les sucres: Formation des melanoidines par voie méthodique. C R Acad Sci 154:66–68, 1912

    Google Scholar 

  22. Fluckiger R, Winterhalter KH, In vitro synthesis of hemoglobin A1C. FEBS Lett 71:356–360, 1976

    Google Scholar 

  23. Phillipou G, Seaborn CJ, Limitations of the fructosamine reaction. Clin Chem 63:409–410, 1990

    Google Scholar 

  24. Fluckiger R, Gallop PM, Measurement of nonenzymatic protein glycosylation. Methods Enzymol 106:77–87, 1984

    Google Scholar 

  25. Lyons TJ, Kennedy L, Non-enzymatic glycosylation of skin collagen in patients with type I (insulin-dependent) diabetes mellitus and limited joint mobility. Diabetologia 28:2–5, 1985

    Google Scholar 

  26. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H, Infections and diabetes: The case for glucose control. Am J Med 72:439–450, 1982

    Google Scholar 

  27. Brighton MW, Furth AJ, Protein glycation after return to normoglycemia: implications for mild repetitive hyperglycemia. Diabetologia 32:700–701, 1989

    Google Scholar 

  28. Higgins PJ, Bunn HF, Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J Biol Chem 256:5204–5208, 1981

    Google Scholar 

  29. Haitas S, Barnes AJ, Moore JC, Turner RC, Loss of diabetic control and increased protein glycosylation following minor intercurrent infections. Diabetic Med 2:23–26, 1985

    Google Scholar 

  30. Rodriguez-Segade S, Lojo S, Camina MF, Paz JM, Delrio R, Effects of various serum proteins on quantification of fructosamine. Clin Chem 35:134–138, 1989

    Google Scholar 

  31. Jones AF, Winkler JW, Thormalley PJ, Lunec J, Jennings PE, Barnett AH, Inhibitory effect of superoxide dismutase on fructosamine assay. Clin Chem 33:147–149, 1987

    Google Scholar 

  32. Tas S, Zein El Din R, Automated fructosamine assay with improved accuracy used to quantify nonenzymatic glycation of serum proteins in diabetes mellitus and chronic renal failure. Clin Chem 36:1825–1830, 1990

    Google Scholar 

  33. Siedel J, Vogt B, Kerschner L, Ziegenhorn J Serum fructosamine assay: two different color reagents compared with reference to a HPLC-procedure (abstract). Clin Chem 34:797, 1988

    Google Scholar 

  34. Hillson RM, Why are people with diabetes admitted to hospital? Diabetic Med 6 [Suppl 2]:P81, 1989

  35. Spiro RG, Search for a biochemical basis of diabetic microangiopathy. Diabetologia 12:1–14, 1976

    Google Scholar 

  36. Mackiewicz A, Kushner I, Role of IL-6 in acute phase protein glycosylation. Ann NY Acad Sci 557:514–516, 1992

    Google Scholar 

  37. Sharma C, Dolferes ER Jr, Radhakrihnamurthy B, Depaolo CJ, Berenson GS, Hepatic glycoprotein synthesis in streptozotocin diabetic rats. Biochem Int 15:395–401, 1987

    Google Scholar 

  38. Miller LL, Treat BE, Fridd B, Wemett D, Effects of streptozotocin diabetes in the rat on blood levels of ten specific plasma proteins and on their net biosynthesis by the isolated perfused liver. Hepatology 11:635–645, 1990

    Google Scholar 

  39. Chapman A, Copeland P, Davidson S, Calhoun JC IV, Abnormality in ASN-linked oligosaccharides. Biochem Biophys Acta 1077:265–272, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lab. Exp. Med., (Université Libre de Bruxelles), B-6110, Montigny-le Tilleul, Belgium

    M. Vanhaeverbeek, D. Brohee, A. Lefevre, P. Piro, B. Kennes & P. Neve

  2. Dept. Intern. Med., C.H.U. A. Vésale, B-6110, Montigny-le Tilleul, Belgium

    M. Vanhaeverbeek, D. Brohee, A. Lefevre, P. Piro, B. Kennes & P. Neve

Authors
  1. M. Vanhaeverbeek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Brohee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Lefevre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Piro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Kennes
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Neve
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vanhaeverbeek, M., Brohee, D., Lefevre, A. et al. Thiobarbiturate and fructosamine assays: significance and interest of the borohydride blank. Acta Diabetol 31, 43–46 (1994). https://doi.org/10.1007/BF00580760

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00580760

Key words

Search

Navigation